Arbutus Biopharma
ABUS
ABUS
77 hedge funds and large institutions have $616M invested in Arbutus Biopharma in 2015 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
+28
Holders Change %
+57.14%
% of All Funds
2.05%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
46
Increased
17
Reduced
8
Closed
18
Calls
$10.3M
Puts
$3.78M
Net Calls
+$6.52M
Net Calls Change
+$1.49M
Top Buyers
| 1 |
QF
1
QVT Financial
New York
|
$280M |
| 2 |
RCM
2
RA Capital Management
Boston,
Massachusetts
|
$47.4M |
| 3 |
AWG
3
Alpha Wave Global
New York
|
$38.8M |
| 4 |
BRC
4
Blue Ridge Capital
New York
|
$29.7M |
| 5 |
5
D.E. Shaw & Co
New York
|
$29.4M |
